{
  "id": 20826261,
  "title": "Johnson & Johnson Delivered 'Immaculate' Prostate Cancer Data at ESMO. Here's Why Investors Should Care",
  "url": "https://urgent.news/2026/11/19/johnson-johnson-delivered-immaculate-prostate-cancer-data-at-esmo",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-19T23:45:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/11/19/johnson-johnson-delivered-immaculate-prostate-canc/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "Johnson & Johnson's $3.05 billion Halda bet is already paying off in the clinic.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Johnson & Johnson Delivered 'Immaculate' Prostate Cancer Data at ESMO. Here's Why Investors Should Care",
        "url": "https://urgent.news/2026/11/20/johnson-johnson-delivered-immaculate-prostate-cancer-data-at-esmo",
        "published": "2026-11-20T00:05:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}